Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Hair loss drugs may cause sexual issues and infertility in men.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Finasteride helps hair growth but may cause sexual side effects and depression.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Key genes linked to hair growth and cancer were identified in hairless mice.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Older adults use lifestyle drugs to improve life quality and appearance, but caution is needed due to side effects and potential abuse.